Introduction

15
During growth, there is an accumulation of tissue protein, whereas in the adult, the tissue protein 16 content is in balance. On the other hand, injury and disease are frequently accompanied by loss of protein from 17 body tissues, and one of the aims of treatment is to minimize this loss and promote its recovery by nutritional and 18 other therapies. A better understanding of the processes that influence tissue protein gain and loss can be 19 achieved by direct measurement of protein synthesis and degradation in tissues. These two complex and 20 opposing processes are controlled by a variety of hormonal, chemical and physical signals, resulting in growth in 21 3 the immature, and maintenance of protein balance in the healthy adult individual. An imbalance resulting from 1 modulation of either synthesis or degradation is the cause of protein gain or loss, but in this article we will 2 concentrate mainly on studies of protein synthesis in human muscle, and its modulation by nutritional factors in 3 health and in pathological states.
4
Measurement of Protein Synthesis. 5 Rates of protein synthesis have been measured for many years in cells and tissues in vitro and in 6 animal models using radioactively labeled amino acids. These studies have made an invaluable contribution to 7 our understanding of protein metabolism, but their relevance to human disease can only be assessed by direct 8 measurements in humans, using isotopic labeling techniques. Risk of radiation limits the use of radioactive 9 isotopes in humans, however, and they have now been largely replaced by their stable isotope counterparts. 10 The limitations of tissue sampling in humans and the continual improvement of the mass spectrometers used to 11 measure stable isotopes have resulted in the development of a variety of approaches for measuring rates of 12 protein synthesis and degradation in the whole body. These techniques have been used extensively (for reviews 13 see Waterlow et al, 1978 ,Garlick et al, 1994 , Young 1987 ) and have given rise to much useful information, but 14 suffer from the limitation that changes in whole body rates of protein turnover cannot be ascribed with any 15 certainty to any particular organ, tissue or body compartment. For example, animal studies have shown that 16 inflammation resulting from subcutaneous injection of turpentine is associated with a fall in protein synthesis in 17 skeletal muscle, but a rise in the liver (Ballmer et al, 1991) . These changes would not be detected by the 18 whole-body technique. Over the last decade or so, therefore, there has been an increasing interest in 19 measurements of protein synthesis rates in individual tissues of human subjects. 20 The general procedure for measuring protein synthesis in an individual tissue or organ in vivo is to 21 4 inject or infuse an amino acid labeled with the chosen isotope into the bloodstream and to make measurements 1 during the period that it is incorporated into tissue protein. To determine rates of protein synthesis directly, a 2 tissue sample is taken at the end of a period of time t (days) and the enrichment of the amino acid in protein (E p ) 3 is determined. The fractional rate of synthesis (k s , in % per day) is then calculated from the equation: k s x E f x t 4 = E p x 100. The other necessary information is the average enrichment of the free amino acid that is being 5 incorporated into protein. This latter measurement has given rise to much debate. Theoretically this 6 measurement should be made on the pool of aminoacyl tRNA in the tissue, but this is complicated by the 7 extremely rapid rate of turnover of this pool and its small size, requiring large tissue samples. For most practical 8 purposes the alternative is to use either the plasma or the tissue (intracellular) free amino acid. However, the 9 isotopic enrichment in these two compartments is not necessarily the same, which has led to uncertainty in the 10 calculated values for protein synthesis and has been influential in determining the way in which the labeled amino 11 acid is administered. Both of the procedures commonly used today were originally suggested by the work of 12 R.B. Loftfield in the 1950's. When a labeled amino acid was given to rats by continuous intravenous infusion, 13 the isotopic enrichments (specific radioactivities) in the plasma and tissues rapidly rose to constant (plateau) 14 values, but in the tissues the values remained substantially lower than in the plasma (Loftfield and Harris, 1956 ). 15 The interpretation made was that the intracellular pool was derived partially by transport of amino acid into the 16 cell from the plasma and partially from the degradation of unlabeled protein. Moreover, it would be difficult to 17 calculate rates of protein synthesis with confidence, because it was not known which, if either, of these two 18 values would be appropriate as the precursor enrichment. Rates of protein synthesis were not therefore 19 calculated, and instead a different method of label administration was devised, with the aim of making the intra- 20 and extracellular enrichments the same, thus minimizing the ambiguity. This was achieved by injecting the 21 labeled amino acid together with a large amount of unlabeled amino acid, sufficiently to dominate (flood) the 22 small endogenous pool of unlabeled free amino acid (Loftfield and Eigner, 1958) . This approach has become 1 known as the "flooding method". Both of these approaches have been used extensively in animals with 2 radioactively labeled amino acids (eg. Garlick et al, 1983 , McNurlan et al, 1979 , and in humans with stable 3 isotopes (Garlick and McNurlan, 1998 , Garlick et al, 1994 , Rennie et al, 1994 . 4 The constant infusion method has been used for many investigations of muscle protein synthesis in 5 volunteers and patients Rennie et al, 1994) . Its advantages are that simultaneous measurement can also be 6 made of whole-body protein turnover, and that the labeled amino acid is given as a tracer, unlike the flooding 7 method, and therefore should not disturb metabolism. Its disadvantages are the need for a metabolic steady 8 state during the infusion, which might preclude observations when acute metabolic changes in are occurring (eg. 9 after a meal, in acute illness or during surgery), and the uncertainty regarding the precursor enrichment when 10 direct measurements of aminoacyl tRNA are not made. However, as most of the work described here 11 employed the flooding approach, this method will be described in more detail. 12 Early investigations with the flooding approach in rats showed that 0.1mmol/100g body weight of between 0 and 90 min (Garlick et al, 1989) . The value obtained for muscle protein synthesis rate was 1.86 1 sem 0.12 %/day when the precursor was taken to be the plasma leucine and 1.95 sem 0.12 %/day when the 2 plasma KIC was used as an index of intracellular labeling (Garlick et al, 1989 there were corresponding increases in protein retention, as a result of an increase in protein synthesis and a 7 smaller increase in degradation (Mitton et al, 1991) . This suggests the same sensitivity of protein synthesis to 8 feeding as in the growing rat. Moreover, when measurements of the response of muscle protein synthesis to 1982), and these differences in response need to be resolved. overt muscle wasting do not have lower rates of muscle protein synthesis (Fig 2, McNurlan et al, 1997) ).
13
Muscle Protein Synthesis in Pathological States
11
The factors that cause the decrease in protein synthesis and protein wasting are therefore not clear at 12 present, as the rate of protein synthesis does not appear to be related to the degree of stress or trauma. This is 13 particularly apparent in critically ill patients, who might display either reduced or elevated rates of protein 14 synthesis (Fig.2) , which do not relate well to the clinical condition of the patient (Essén et al, 1998, Gamrin et al, 15 2000). As modulation of protein degradation is also thought to be important in pathological states, combined 16 measurements of synthesis and degradation may be needed in future studies. 17 Because protein wasting contributes substantially to morbidity and mortality, there has been much 18 interest in the potential benefits of nutritional support. However, studies in patients following cholecystectomy 19 showed that postoperative intravenous nutrition did not diminish the inhibition of protein synthesis (Essén et al, 20 1993 Protein wasting is also a characteristic of chronic infectious diseases, in particular in patients with 13 AIDS. However, as indicated above, protein synthesis is not depressed. As shown in Fig 3, were wasted (Fig. 3) . This suggests that the trophic mechanisms involved in maintaining muscle mass, such as 1 growth hormone and IGF-I, have become progressively deficient as the HIV disease advances (McNurlan et al,   2 1997). In an attempt to discover the mechanisms involved, the plasma from these patients was analyzed for The plasma concentration of sTNFR-2 may be a measure of the ongoing level of immune activation, as its 8 plasma half-life is much longer than that of TNFa. Hence, this correlation suggests that resistance to GH 9 treatment, and hence the decrease in muscle responsiveness to IGF-I, might be the result of an inflammatory 10 process involving TNF.
A number of pathological states involving wasting are associated with acidosis, which has received 12 relatively little attention as a possible mediator of protein wasting. In the study of protein synthesis in muscle of 13 critically ill patients (Fig.2 , Essen et al, 1998), the wide variation in rates were partially explained by variations in 14 the arterial pH. Also, there have been studies suggesting that acidosis causes negative nitrogen and leucine 15 balance (Ballmer et al, 1995 , Reaich et al, 1992 and that proteolysis in muscle is enhanced (Mitch et al, 1993 ). 16 Our own work has led to the conclusion that muscle protein synthesis is inhibited by acidosis and may also be 
Conclusions
11
During growth, muscle protein synthesis is especially sensitive to stimulation by nutrient intake, 12 through the combined actions of insulin and amino acids, particularly the branched chain amino acids. However, 13 these anabolic responses appear to be blunted in adulthood in rats, and possibly in humans also. In the adult 14 human, pathological states, such as injury and infection, result in muscle protein wasting, which in the case of synthesis in rats by acute metabolic acidosis. FASEB J 13:A909. 
